BioVaxys Technology Corp. (CSE:BIOV)
Canada · Delayed Price · Currency is CAD 0.1600
-0.0050 (-3.03%)
At close: Feb 9, 2026
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 7.06 million as of February 9, 2026. Its market cap has decreased by -60.48% in one year.
Market Cap
7.06M
Enterprise Value
7.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 7.06M, a decrease of -73.93%. That is a compound annual growth rate of -22.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 7.06M | -27.27% |
| Dec 31, 2025 | 9.70M | -41.13% |
| Dec 31, 2024 | 16.48M | 127.10% |
| Dec 29, 2023 | 7.26M | -47.89% |
| Dec 30, 2022 | 13.92M | -26.37% |
| Dec 31, 2021 | 18.91M | 32.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmala Biotech Holdings | 10.89M |
| Glow Lifetech | 9.98M |
| Cytophage Technologies | 9.81M |
| COSCIENS Biopharma | 8.72M |
| Marvel Biosciences | 8.12M |
| PharmaTher Holdings | 7.28M |
| Kane Biotech | 7.26M |
| Restart Life Sciences | 5.94M |